Detalles de la búsqueda
1.
Baricitinib in Patients with Refractory Rheumatoid Arthritis.
N Engl J Med
; 374(13): 1243-52, 2016 Mar 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-27028914
2.
Efficacy and safety of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional DMARDs in patients with RA at week 97 (SUMMACTA).
Ann Rheum Dis
; 75(1): 68-74, 2016 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-26056119
3.
A randomised, double-blind, parallel-group study of the safety and efficacy of subcutaneous tocilizumab versus intravenous tocilizumab in combination with traditional disease-modifying antirheumatic drugs in patients with moderate to severe rheumatoid arthritis (SUMMACTA study).
Ann Rheum Dis
; 73(1): 69-74, 2014 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-23904473
4.
Evaluation of abatacept administered subcutaneously in adults with active rheumatoid arthritis: impact of withdrawal and reintroduction on immunogenicity, efficacy and safety (phase Iiib ALLOW study).
Ann Rheum Dis
; 71(1): 38-44, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21917824
5.
Immunogenicity, safety, and efficacy of abatacept administered subcutaneously with or without background methotrexate in patients with rheumatoid arthritis: results from a phase III, international, multicenter, parallel-arm, open-label study.
Arthritis Care Res (Hoboken)
; 65(5): 718-28, 2013 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-23097311
6.
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.
Arthritis Rheum
; 46(5): 1309-18, 2002 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-12115238
Resultados
1 -
6
de 6
1
Próxima >
>>